Azitra AZTR
NYSE AZTR
$0.14 +0.01 (+6.53%)
As of: Aug 21, 2026 · 1:38 PM EDT

Azitra (AZTR) EBIT Margin (2022 - 2024)

Azitra's (AZTR) quarterly EBIT Margin came in at 35470.4% in Q2 2024, down 3464041.0% YoY from N/an in Q3 2023, and down 1192.19% on a QoQ basis from 2744.97% in Q4 2023.

Azitra (AZTR) EBIT Margin (2022 - 2024) Analysis & Trends

Azitra (AZTR) has 3 years of EBIT Margin data on file, last reported at 35470.4% in Q2 2024.

  • Quarterly EBIT Margin fell 3464041.0% year-over-year to 35470.4% in Q2 2024, while the trailing twelve-month figure through Jun 2025 was 151132.71% (down 14866186.0% YoY) and the FY2024 annual result came in at 146468.53%, down 14538245.0% from the prior year.
  • EBIT Margin slipped to 35470.4% in Q2 2024, from 2744.97% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 641.69% in Q3 2023 to a low of 35470.4% in Q2 2024.
  • A 3-year average of 7156.69% and a median of 2600.95% in 2022 frame the typical range for EBIT Margin.
  • Annual changes were most pronounced in 2023 — EBIT Margin soared 610123 bps — and 2024, when it plunged 3464041 bps.
  • Tracing AZTR's EBIT Margin over 3 years: stood at 8846.2% in 2022, then soared by 69 bps to 2744.97% in 2023, then slumped by 1192 bps to 35470.4% in 2024.
  • The last three EBIT Margin figures came in at 35470.4% (Q2 2024), 2744.97% (Q4 2023), and 641.69% (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Vertex Pharmaceuticals 139.25 Bn 131.40 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 86.04 Bn 78.05 Bn 3.93 Bn 30.15%
3 Argenx Se 65.43 Bn 60.25 Bn 1.37 Bn 32.54%
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn -562.07%
5 BeOne Medicines 42.10 Bn 37.00 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 31.61 Bn 28.31 Bn 992.69 Mn 17.93%
7 BioNTech SE 28.03 Bn 9.63 Bn 668.28 Mn -35.57%
8 Insmed 27.49 Bn 26.33 Bn 358.27 Mn -0.36%
9 Royalty Pharma 27.33 Bn 26.49 Bn - 19.75%
10 Azitra 2.61 Mn 2.61 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 -35,470.40%
Dec 31, 2023 -2,744.97%
Sep 30, 2023 -641.69%
Jun 30, 2023 -829.99%
Mar 31, 2023 -1,375.77%
Dec 31, 2022 -8,846.20%
Sep 30, 2022 -4,887.53%
Jun 30, 2022 -2,456.93%